Difference between revisions of "Tigatuzumab (CS-1008)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Investigational" to "Category:Investigational drugs") |
||
| Line 7: | Line 7: | ||
[[Category:Anti-TRAIL-R2 antibodies]] | [[Category:Anti-TRAIL-R2 antibodies]] | ||
| − | [[Category:Investigational]] | + | [[Category:Investigational drugs]] |
Revision as of 17:43, 3 February 2019
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)